Status:
COMPLETED
A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain
Lead Sponsor:
Bracco Diagnostics, Inc
Conditions:
Brain Pathology
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study aims at a direct comparison between Multihance and a validated comparator like Omniscan in a cross-over individual design in patients with brain tumors to confirm the superior overall diagn...
Eligibility Criteria
Inclusion
- 18 yrs of age or older; provide written informed consent; scheduled to undergo MRI; willing to undergo 2 MRI exams within 14 days
Exclusion
- Known allergy to one or more ingredients in the test agents; severe CHF (Class IV); suffered stroke one year ago; pregnancy or lactating females; contraindications to MRI; severe claustrophobia; scheduled to receive surgery prior to or between the two MRI exams, or steroids or radiosurgery between the two MRI exams
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00323102
Start Date
May 1 2006
End Date
March 1 2007
Last Update
January 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bracco Diagnostics, Inc.
Princeton, New Jersey, United States, 08540